Protective Effect Of Betulinic Acid For Treating Unpredictable Chronic Mild Stress-Induced Depression In Mice By Inhibiting Brain Rip140 Activation

Yu Chen,Wei Jiang,Yuan Chen,Xiao-Lan Chen,Wei Chen,Feng-Tao Li,Yong-Jun Li,Xin Yao
2017-01-01
Abstract:The present study was designed to evaluate whether betulinic acid (BA) could exert an antidepressant-like effect in mice exposed to unpredictable chronic mild stress (UCMS) and to explain its underlying mechanisms. Behavioral changes, which was investigated through sucrose preference test (SPT), open field test (OFT), forced swimming test (FST) and tail suspension test (TST), indicated that BA (20 mg/kg, 40 mg/kg) could improve depression symptoms. Cytokines interleukin (IL)- 6, IL-1 beta and tumor necrosis factor (TNF)-alpha in hippocampus presented significant decreases with exposure to betulinic acid. The expressions of RIP140, p-NF-kappa Bp65, p-I kappa B alpha, p-IKK alpha and p-IKK beta were inhibited with BA (20 mg/kg, 40 mg/kg) treatment according to western blot analysis, while immunohistochemical analysis also exhibited certain alterations of RIP140, p-NF-kappa Bp65. The current results suggested the potential antidepressant-like roles of betulinic acid in the UCMS-induced mouse model via inhibiting brain RIP140 activation.
What problem does this paper attempt to address?